Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCKa-hy study: Quantitative evaluation of conjunctival hyperemia with ROCK inhibitor and α2 adrenoceptor agonist
jRCTs061240050Recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ripasudil and brimonidine in open-angle glaucoma (OAG), sponsored by Kowa Company, Ltd. Started Oct 2024; status: recruiting.
02
Drugs
ripasudilbrimonidine
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on jRCTs061240050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061240050.